Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Effect of Formulation Factors and Oxygen Levels on the Stability of Aqueous Injectable Solution Containing Pemetrexed.

Won DH, Park H, Ha ES, Kim YM, Hwang HD, Jang SW, Kim MS.

Pharmaceutics. 2020 Jan 6;12(1). pii: E46. doi: 10.3390/pharmaceutics12010046.

2.

Development of a Resveratrol Nanosuspension Using the Antisolvent Precipitation Method without Solvent Removal, Based on a Quality by Design (QbD) Approach.

Kuk DH, Ha ES, Ha DH, Sim WY, Lee SK, Jeong JS, Kim JS, Baek IH, Park H, Choi DH, Yoo JW, Jeong SH, Hwang SJ, Kim MS.

Pharmaceutics. 2019 Dec 17;11(12). pii: E688. doi: 10.3390/pharmaceutics11120688.

3.

Physical stability of dry powder inhaler formulations.

Shetty N, Cipolla D, Park H, Zhou QT.

Expert Opin Drug Deliv. 2019 Dec 13:1-20. doi: 10.1080/17425247.2020.1702643. [Epub ahead of print]

PMID:
31815554
4.

Pharmacokinetic Study of a Soft Gelatin Capsule and a Solid-Supersaturatable SMEDDS Tablet of Dutasteride in Beagle Dogs.

Kim JS, Ha ES, Park H, Choi DH, Kim MS, Baek IH.

Eur J Drug Metab Pharmacokinet. 2019 Nov 29. doi: 10.1007/s13318-019-00594-4. [Epub ahead of print]

PMID:
31782125
5.

Effect of Stabilizers on Encapsulation Efficiency and Release Behavior of Exenatide-Loaded PLGA Microsphere Prepared by the W/O/W Solvent Evaporation Method.

Park H, Ha DH, Ha ES, Kim JS, Kim MS, Hwang SJ.

Pharmaceutics. 2019 Nov 24;11(12). pii: E627. doi: 10.3390/pharmaceutics11120627.

6.

Preparation and Evaluation of Resveratrol-Loaded Composite Nanoparticles Using a Supercritical Fluid Technology for Enhanced Oral and Skin Delivery.

Ha ES, Sim WY, Lee SK, Jeong JS, Kim JS, Baek IH, Choi DH, Park H, Hwang SJ, Kim MS.

Antioxidants (Basel). 2019 Nov 14;8(11). pii: E554. doi: 10.3390/antiox8110554.

7.

Evaluation of co-delivery of colistin and ciprofloxacin in liposomes using an in vitro human lung epithelial cell model.

Chai G, Park H, Yu S, Zhou F, Li J, Xu Q, Zhou QT.

Int J Pharm. 2019 Oct 5;569:118616. doi: 10.1016/j.ijpharm.2019.118616. Epub 2019 Aug 12.

PMID:
31415873
8.

Lung Segmentation on HRCT and Volumetric CT for Diffuse Interstitial Lung Disease Using Deep Convolutional Neural Networks.

Park B, Park H, Lee SM, Seo JB, Kim N.

J Digit Imaging. 2019 Dec;32(6):1019-1026. doi: 10.1007/s10278-019-00254-8.

PMID:
31396776
9.

Correlations between surface composition and aerosolization of jet-milled dry powder inhaler formulations with pharmaceutical lubricants.

Mangal S, Park H, Nour R, Shetty N, Cavallaro A, Zemlyanov D, Thalberg K, Puri V, Nicholas M, Narang AS, Zhou QT.

Int J Pharm. 2019 Sep 10;568:118504. doi: 10.1016/j.ijpharm.2019.118504. Epub 2019 Jul 9.

PMID:
31299339
10.

Simultaneous Particle Size Reduction and Homogeneous Mixing to Produce Combinational Powder Formulations for Inhalation by the Single-Step Co-Jet Milling.

Ling J, Mangal S, Park H, Wang S, Cavallaro A, Zhou QT.

J Pharm Sci. 2019 Sep;108(9):3146-3151. doi: 10.1016/j.xphs.2019.05.011. Epub 2019 May 18.

11.

Synthesis of Bimetallic Conductive 2D Metal-Organic Framework (Cox Niy -CAT) and Its Mass Production: Enhanced Electrochemical Oxygen Reduction Activity.

Yoon H, Lee S, Oh S, Park H, Choi S, Oh M.

Small. 2019 Apr;15(17):e1805232. doi: 10.1002/smll.201805232. Epub 2019 Apr 1.

PMID:
30932335
12.

Effects of the antibiotic component on in-vitro bacterial killing, physico-chemical properties, aerosolization and dissolution of a ternary-combinational inhalation powder formulation of antibiotics for pan-drug resistant Gram-negative lung infections.

Mangal S, Huang J, Shetty N, Park H, Lin YW, Yu HH, Zemlyanov D, Velkov T, Li J, Zhou QT.

Int J Pharm. 2019 Apr 20;561:102-113. doi: 10.1016/j.ijpharm.2019.02.018. Epub 2019 Feb 21.

PMID:
30797863
13.

Understanding the Impacts of Surface Compositions on the In-Vitro Dissolution and Aerosolization of Co-Spray-Dried Composite Powder Formulations for Inhalation.

Mangal S, Xu R, Park H, Zemlyanov D, Shetty N, Lin YW, Morton D, Chan HK, Li J, Zhou QT.

Pharm Res. 2018 Nov 7;36(1):6. doi: 10.1007/s11095-018-2527-x.

14.

Improved Physical Stability and Aerosolization of Inhalable Amorphous Ciprofloxacin Powder Formulations by Incorporating Synergistic Colistin.

Shetty N, Ahn P, Park H, Bhujbal S, Zemlyanov D, Cavallaro A, Mangal S, Li J, Zhou QT.

Mol Pharm. 2018 Sep 4;15(9):4004-4020. doi: 10.1021/acs.molpharmaceut.8b00445. Epub 2018 Aug 3.

15.

Composite particle formulations of colistin and meropenem with improved in-vitro bacterial killing and aerosolization for inhalation.

Mangal S, Park H, Zeng L, Yu HH, Lin YW, Velkov T, Denman JA, Zemlyanov D, Li J, Zhou QT.

Int J Pharm. 2018 Sep 5;548(1):443-453. doi: 10.1016/j.ijpharm.2018.07.010. Epub 2018 Jul 3.

16.

Influence of excipients on physical and aerosolization stability of spray dried high-dose powder formulations for inhalation.

Shetty N, Park H, Zemlyanov D, Mangal S, Bhujbal S, Zhou QT.

Int J Pharm. 2018 Jun 10;544(1):222-234. doi: 10.1016/j.ijpharm.2018.04.034. Epub 2018 Apr 18.

Supplemental Content

Loading ...
Support Center